Related Experiment Video
Updated: Jul 25, 2026

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
Published on: June 25, 2010
Phenylketonuria in South Africa. A report on the status quo
H W Hitzeroth1, C E Niehaus, D C Brill
1Genetic Services, Department of National Health and Population Development, Pretoria.
Insights
Newborn screening for phenylketonuria (PKU) in South Africa found a very low incidence. The pilot program concluded that PKU screening is not cost-effective due to low prevalence and competing health priorities.
Area of Science:
- Medical Genetics
- Public Health
- Neonatal Care
Background:
- A pilot newborn screening program for amino acidopathies, particularly phenylketonuria (PKU), was implemented in South Africa during the 1980s.
- The program was motivated by the high priority of PKU screening in Europe and North America and the assumed high incidence in South Africans of European descent.
Purpose of the Study:
- To evaluate the cost-effectiveness and justification of newborn screening for PKU and other amino acidopathies in South Africa.
- To present the findings of a pilot screening program conducted between 1979 and 1986.
Main Methods:
- Screening of 59,600 newborns in the Pretoria area over 8 years (1979-1986).
- Statistical analysis using Poisson distribution and 95% confidence intervals to estimate the true incidence of PKU.
Main Results:
- Only one case of PKU and one case of tyrosinaemia were detected among the 59,600 newborns screened.
- The estimated true incidence of PKU was found to be no more than 1/20,000 newborns, statistically compatible with the observed low rate.
Conclusions:
- Newborn screening for PKU and other amino acidopathies is not considered cost-effective or justifiable in South Africa.
- The low incidence, demographic factors, and pressing health priorities do not support the continuation of such screening programs.
Abstract:
During the 1980s a pilot newborn screening programme for the early detection (and treatment) of amino acidopathies, especially phenylketonuria (PKU), was conducted by the Department of National Health and Population Development. The motivation for this pilot programme was the high priority accorded PKU screening in Europe and North America and the presumed similarly high incidence of this condition among South Africans of European origin. From a cohort of 59,600 newborns screened in the Pretoria area over a period of 8 consecutive years (1979-1986), only 1 case of PKU (and 1 of tyrosinaemia) was found. Statistically this result is compatible (Poisson distribution, 95% confidence interval) with a 'true' incidence of not more than 3/59,600 (or about 1/20,000) newborns. It is concluded from this result and other relevant information that newborn screening for PKU and other amino acidopathies is not cost-effective and justifiable, especially against the background of prevailing demographic conditions and more pressing health priorities in South Africa. This particular screening programme was discontinued in 1986. The results and conclusions are presented here for the record.
Related Concept Videos
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Inborn Errors of Metabolism
Serum Studies: Renal Function Tests
Chronic Kidney Disease III: Interprofessional Care
Diabetic Ketoacidosis l: Introduction

